Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis [NA]
A clinical trial evaluating electrical brain stimulation for secondary symptoms in multiple sclerosis has completed. Sponsor: The National B…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effect of Multimodal Exercise Training in Patients With Multiple Sclerosis [NA]
This update describes an ongoing clinical trial evaluating the effects of multimodal exercise training in people with multiple sclerosis. Th…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial evaluating Ublituximab (Briumvi) for early forms of relapsing multiple sclerosis is currently recruiting. Sponsored…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
This clinical trial is evaluating the effects of combining ocrelizumab with GLP-1 receptor agonists in people with multiple sclerosis and is…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial evaluating early diffusion MRI changes after two years of treatment with natalizumab (Tysabri) in patients with mul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Serious Game Rehabilitation and Brain Plasticity in MS [NA]
This clinical trial investigates serious game-based rehabilitation and brain plasticity in people with multiple sclerosis. The study is curr…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue [NA]
A factorial optimization trial sponsored by the University of Washington is testing which cognitive behavioral therapy components best reduc…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project [Phase 3]
A Phase 3 clinical trial in multiple sclerosis evaluating an alternate pre-medication strategy for anti-CD20 therapy; the study is not yet r…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effects of Qigong Therapy in MS Patients [NA]
An update on an active-but-not-recruiting clinical trial at Baskent University evaluating qigong therapy for multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis [NA]
A University Health Network trial in recruiting to evaluate new approaches aimed at improving balance and neuroplasticity in people with Mul…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Using Motor Imagery-based Brain-computer Interface With Multiple Sclerosis Patients. [NA]
A clinical trial update describes evaluating a motor imagery-based brain-computer interface in multiple sclerosis patients. The study status…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Common and Specific Information From Neuroimaging and Smartphone
This clinical trial update from Nantes University Hospital describes an ongoing study on multiple sclerosis leveraging neuroimaging and smar…
-
FDA approval · 2026-03-12FDA Approved: FINGOLIMOD — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Fingolimod from Quallent Pharmaceuticals Health LLC under an ANDA, updating the approved fingoli…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating autologous mesenchymal stem cells as a regenerative treatment for multiple sclerosis, currently active…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)
A completed clinical trial evaluating inertial units as a medical device to assist balance and coordination in people with Multiple Sclerosi…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Longitudinal Assessment of Iron Rims in MS Lesions
ClinicalTrials.gov listing for a longitudinal study evaluating iron rims in multiple sclerosis lesions, sponsored by Nottingham University H…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients
This entry notes an ongoing clinical trial evaluating consolidation therapy with cladribine for relapsing multiple sclerosis; the study is c…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Impact of Neuropsychological Disorders in Multiple Sclerosis [NA]
This clinical trial update indicates the study on neuropsychological disorders in multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating clemastine fumarate as a myelin repair therapy in patients with acute demy…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of a Spasticity Management Program for People With Multiple Sclerosis [NA]
A completed VA Office of Research and Development–sponsored clinical trial evaluated a spasticity management program for people with Multipl…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial is recruiting to assess changes in multi-parametric MRI in people with Multiple Sclerosis treated with C…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis [Phase 2]
Phase 2 study evaluating N-acetylcysteine for neuroprotection in progressive multiple sclerosis; currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Autoimmune Intervention Mastery Course Study [NA]
Clinical trial update indicates the Autoimmune Intervention Mastery Course Study is currently recruiting participants for several conditions…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
This clinical trial update describes an active-not-recruiting multimodal study examining mechanisms of disease severity in Multiple Sclerosi…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Validity and Reliability of Timed Up and Go Test in Dual-Task Conditions for Multiple Sclerosis Patients
This document describes an ongoing clinical trial evaluating the validity and reliability of the Timed Up and Go test under dual-task condit…